Early Implanon Discontinuation and Associated Factors among Implanon User Women in Debre Tabor Town, Public Health Facilities, Northwest Ethiopia, 2016

Asaye, Mengstu Melkamu; Nigussie, Tewodros Syoum; Ambaw, Worku Mequannt

doi:10.1155/2018/3597487

Cited by 42 publications

(82 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…13 However, the current proportion is lower than a study conducted in Debre Tabor -65%. 16 This variation might be due to study nature or study participants. In the Debre Tabor study, participants were both urban and rural residents, but urban only in this study.…”

Section: Discussionmentioning

confidence: 99%

“…This is consistent with studies conducted in Abakaliki, southeast Nigeria, Debre Tabor, Arsi, Oromia, Jos, Nigeria, and Tigray. 6,9,14,16,17 Possible reason might be exposure to side effects contributing to discontinuation. In addition to this, respondents who had discontinued LARC due to side effects might have been intolerant of the side effects and feared happening different complications with their health in the future.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

<p>Discontinuation of Reversible Long-Acting Contraceptive and Associated Factors among Female Users in Health Facilities of Hawassa City, Southern Ethiopia: Cross-Sectional Study</p>

Abebe¹,

Assefa²,

Mengistie³

2020

OAJC

View full text Add to dashboard Cite

Background: Despite improvement in the availability and use of reversible long-acting contraception, discontinuation is becoming a public health concern. A significant proportion of women discontinuing the service before its due date, which is of concern in the health system with regard to its consequences, may lead to a program failure. In addition, there is a paucity of information on discontinuation of reversible long-acting contraceptives and associated factors in the study area. Therefore, this study aimed to assess discontinuation of reversible long-acting contraceptives and associated factors among female users in health facilities of Hawassa city, southern Ethiopia, 2019. Methods: Institution-based cross-sectional design was used. Systematic sampling was used to select study participants. Women who were users of long-acting contraceptives and had come to selected health facilities for method-related reasons were included in the study. Data collectors approached and recruited participants before they contacted their care providers. Data were collected from study subjects using a pretested, structured questionnaire through face-to-face interviews after participants had contacted care providers. Results are presented using the crude and adjusted ORs with corresponding 95% CIs. Results: The overall proportion of reversible long-acting contraceptive discontinuation was 56.6% (95% CI 52.30%, 61.10%). Maternal education at primary level (AOR 2.33, 95% CI 1.15-4.74), lack of counseling (AOR 2.50, 95% CI 1.01-6.18), side effects (AOR 2.10, 95% CI 1.31-3.34), and desire to be pregnant (AOR 2.22; 95CI 1.50-3.30) were the major factors in discontinuation. Conclusion: In this study, the overall proportion of discontinuation of reversible long-acting contraceptives was high. Maternal education at primary level, lack of counseling, side effects, and desire to be pregnant were the key factors associated with discontinuation of the contraceptives. Health professionals should provide counseling on the side effects before insertion.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

<p>Discontinuation of Reversible Long-Acting Contraceptive and Associated Factors among Female Users in Health Facilities of Hawassa City, Southern Ethiopia: Cross-Sectional Study</p>

Abebe¹,

Assefa²,

Mengistie³

2020

OAJC

View full text Add to dashboard Cite

show abstract

“…In Ethiopia, according to Ethiopian Demographic Health survey (EDHS) in 2011, all modern contraceptive methods discontinuation rate was 37% and among them implant discontinuation rate within 12 months was just 5% and another study conducted in Tigray showed that the Implanon discontinuation rate in 1 year was 16% [ 8 , 9 ]. Studies suggested that pre insertion counseling, education, age of the women and having no children are some of the predictors of early discontinuation [ 10 , 11 ].…”

Section: Introductionmentioning

confidence: 99%

Discontinuation rate of Implanon and its associated factors among women who ever used Implanon in Dale District, Southern Ethiopia

Nageso

Gebretsadik

2018

BMC Women's Health

View full text Add to dashboard Cite

BackgroundEarly discontinuation of the Implanon contraceptive method and reasons for such discontinuation remains a major concern for family planning programs. In less developed countries, contraceptive discontinuation due to health concerns is generally higher, these complaints are often related to service quality. Significant numbers of women become exposed to conception after discontinuation and accidental pregnancies that end up with abortion & stillbirth. The aim of this study was to assess the early discontinuation rate of Implanon and identify its associated factors among women who ever used Implanon in 2016 in Dale district, Southern Ethiopia.MethodsCommunity based cross-sectional study design was conducted from January to February, 2017. A total number of 711 women who ever used Implanon in 2016 were selected using multistage sampling. The data were entered and cleaned in Epi Info and analyzed using SPSS. Multivariate logistic regression analysis was used to determine the effect of factors on the outcome variables. Finally, the results were presented using adjusted odds ratio (AOR) & confidence interval of 95%.ResultEarly Implanon discontinuation rate in this study was 160 (23.4%) with a mean duration of Implanon use of 9.6 ± 2.5 months. The main reasons for discontinuation of Implanon were 55 (34.4%) the facing of side effects. Factors for discontinuation of Implanon were women age 20–24 years (AOR =. 44 (95% CI: 23-. 85), 25–29 years (AOR =. 52 (95% CI: 27-. 96), 35+ years, (AOR =. 08 (95% CI: 02-. 41), less likely to discontinue. Women who weren’t counseled about the side effects during Implanon insertion were 1.93 times (AOR = 1.93 (95% CI: 1.27–2.93), women who didn’t satisfied by the service (AOR = 2.55(CI: 95%: 1.63–3.97), women who didn’t appointed for follow up (AOR = 3.13 (CI: 95%: 2.0–4.95), women who didn’t choose the method by themselves (AOR = 1.83 (CI: 95%: 1.18–2.83) and women who didn’t have information on family planning before Implanon insertion (AOR = 1.52 (CI: 95%: 1.1–2.28) were the predictors of Implanon discontinuation.ConclusionsImplanon discontinuation rate in this study area was high. Appropriate counseling prior to insertion and proper follow up, autonomous choice will improve the continuation rate of Implanon.

show abstract

“…This agrees with works done by other authors in which one of the main reasons for discontinuation of Implanon use was because of side effects. 18,19 CONCLUSION Post-partum Implanon/Nexplanon continuation rates are high and remain as a viable choice for reduction of unplanned pregnancies post-delivery. Within a year Within 2 years…”

Section: Discussionmentioning

confidence: 99%

Postpartum Implanon/Nexplanon continuation rates and associated factors among women who ever used Implanon/Nexplanon in a tertiary hospital in Accra, Ghana

Mumuni

Asah‐Opoku

Ganu

2019

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Background: Postpartum Implanon use serves as an important conduit to bridge the wide gap of unmet need for contraception. The study sought to determine the continuation rates of postpartum Implanon/Nexplanon use and factors associated with it.Methods: A retrospective review of electronic data of 391 women who had received postpartum Implanon/Nexplanon insertions from January 2012 to December 2015 was conducted at a family planning hospital in Accra, Ghana. Continuation rates and factors associated with discontinuation at 6 months, one year and two years post-partum were determined. Data were analysed using IBM Statistical Package for Social Science (SPSS) version 20.Results: A total of 391 postpartum Implanon/Nexplanon insertions were done during study period. Their mean age was 28.51±5.29 years and median parity was 2.0. Continuation rates of postpartum Implanon/Nexplanon at 6 months, 1 year and 2 years post uptake were 94.9%, 92.8% and 86.4% respectively. Women with tertiary level education were 64% less likely to continue Implanon/Nexplanon use at one-year post uptake (OR=0.36, CI=0.16-0.85). Women with education up to Senior High School were 62% less likely to continue postpartum Implanon/Nexplanon use at 2 years after uptake (OR=0.38, CI=0.18-0.81). Women between ages 20 and 29 years were 53% less likely to continue postpartum Implanon/Nexplanon use at 2 years (OR=0.47, CI=0.26-0.86). Reasons for discontinuation of postpartum Implanon/Nexplanon use were wishes to get pregnant and side effects of the method.Conclusions: Post -partum Implanon/Nexplanon continuation rates are high and remain as a viable choice for reduction of unplanned pregnancies post- delivery.

show abstract

Early Implanon Discontinuation and Associated Factors among Implanon User Women in Debre Tabor Town, Public Health Facilities, Northwest Ethiopia, 2016

Cited by 42 publications

References 15 publications

<p>Discontinuation of Reversible Long-Acting Contraceptive and Associated Factors among Female Users in Health Facilities of Hawassa City, Southern Ethiopia: Cross-Sectional Study</p>

<p>Discontinuation of Reversible Long-Acting Contraceptive and Associated Factors among Female Users in Health Facilities of Hawassa City, Southern Ethiopia: Cross-Sectional Study</p>

Discontinuation rate of Implanon and its associated factors among women who ever used Implanon in Dale District, Southern Ethiopia

Postpartum Implanon/Nexplanon continuation rates and associated factors among women who ever used Implanon/Nexplanon in a tertiary hospital in Accra, Ghana

Contact Info

Product

Resources

About